Abstract
Objectives:The aim of this EUnetHTA Rolling Collaborative Review is to inform health policy at the national/regional and at the European level at an early stage in the life-cycle of therapies which interventions are currently undergoing clinical trials, to monitor (ongoing studies and their results) permanently - in the format of a Living Document - potential therapies against covid-19, to present comparative data on effectiveness and safety of potential therapies and to support preparations for an evidence-based purchasing of regional/ national health politicians, if necessary. To avoid redundancies and duplication, the EUnetHTA Rolling Collaborative Review will reuse sources from international initiatives to collect information and data on Covid-19 treatments.
Cite
CITATION STYLE
Salama, H. A. E. S. A., El-Shayeb, M. A. E.-R. H., Hassan, A. N. E.-D., Amin, G. E. E.-D., Allam, M. F., & Ahmed, E. E.-S. (2022). Ivermectin for Treatment of COVID-19? Trends Journal of Sciences Research, 1(1), 30–31. https://doi.org/10.31586/wjmm.2022.474
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.